299-304
REVIEW
Cranial nerve palsy in Wegener’s granulomatosis – Lessons from clinical cases
R. Nowack, P. Wachtler, J. Kunz and N. Rasmussen
305-319
REVIEW
Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis
M. Kolappan, A. P. D. Henderson, T. M. Jenkins, C. A. M. Wheeler-Kingshott and G. T. Plant, et al.
320-332
REVIEW
Acquired hepatocerebral degeneration
J. Ferrara and J. Jankovic
333-338
REVIEW
Epidemiology of vertigo, migraine and vestibular migraine
T. Lempert and H. Neuhauser
339-342
ORIGINAL COMMUNICATION
Case-control study of thromboembolic events associated with IV immunoglobulin
J. B. Caress, L. Hobson-Webb, L. V. Passmore, A. P. Finkbiner and M. S. Cartwright
343-348
ORIGINAL COMMUNICATION
The genetic aetiology of late-onset chronic progressive cerebellar ataxia
A population-based study
Mark Wardle, Elisa Majounie, Mustapha B. Muzaimi, Nigel M. Williams and Huw R. Morris, et al.
349-354
ORIGINAL COMMUNICATION
Fatigue, pain and muscle weakness are frequent after Guillain-Barré syndrome and poliomyelitis
T. Rekand, A. Gramstad and C. A. Vedeler
355-363
ORIGINAL COMMUNICATION
Open AccessMRI and clinical syndrome in dura materrelated Creutzfeldt-Jakob disease
B. Meissner, K. Kallenberg, P. Sanchez-Juan, S. Ramljak and A. Krasnianski, et al.
364-373
ORIGINAL COMMUNICATION
The costs and prognostic characteristics of ischaemic neurological deficit due to subarachnoid haemorrhage in the United Kingdom
Evidence from the MRC International Subarachnoid Aneurysm Trial
Oliver Rivero-Arias, Jane Wolstenholme, Alastair Gray, Andrew J. Molyneux and Richard S. C. Kerr, et al.
374-381
ORIGINAL COMMUNICATION
Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities
H. Tremlett, Y. Zhao, V. Devonshire and and the UBC Neurologists
382-389
ORIGINAL COMMUNICATION
Is the left uncinate fasciculus essential for language?
A cerebral stimulation study
H. Duffau, P. Gatignol, S. Moritz-Gasser and E. Mandonnet
390-395
ORIGINAL COMMUNICATION
Reversible Pisa syndrome in patients with Parkinson’s disease on dopaminergic therapy
A. Cannas, P. Solla, G. Floris, P. Tacconi and A. Serra, et al.
396-404
ORIGINAL COMMUNICATION
Contemporary Encephalitis Lethargica: Phenotype, laboratory findings and treatment outcomes
Robert Lopez-Alberola, Michael Georgiou, George N. Sfakianakis, Carlos Singer and Spyridon Papapetropoulos
405-415
ORIGINAL COMMUNICATION
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL
M. Hutchinson, L. Kappos, P. A. Calabresi, C. Confavreux and G. Giovannoni, et al.
416-419
ORIGINAL COMMUNICATION
Pontocerebellar hypoplasia type III (CLAM): Extended phenotype and novel molecular findings
B. Durmaz, B. Wollnik, O. Cogulu, Y. Li and H. Tekgul, et al.
420-426
ORIGINAL COMMUNICATION
Ocular fixation instabilities in motor neurone disease
A marker of frontal lobe dysfunction?
C. Donaghy, R. Pinnock, S. Abrahams, C. Cardwell and O. Hardiman, et al.
427-435
ORIGINAL COMMUNICATION
Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis
T. Hayton, J. Furby, K. J. Smith, D. R. Altmann and R. Brenner, et al.
436-442
ORIGINAL COMMUNICATION
“Vestibular migraine”: effects of prophylactic therapy with various drugs
A retrospective study
B. Baier, E. Winkenwerder and M. Dieterich
443-449
ORIGINAL COMMUNICATION
Quality of life in survivors after cervical artery dissection
U. Fischer, I. Ledermann, K. Nedeltchev, N. Meier and J. Gralla, et al.
450-456
ORIGINAL COMMUNICATION
Distal and proximal prehension is differentially affected by Parkinson‘s disease
The effect of conscious and subconscious load cues
P. H. Weiss, M. Dafotakis, L. Metten and J. Noth
457-463
ORIGINAL COMMUNICATION
Obstacle stepping in patients with Parkinson’s disease
Complexity does influence performance
J. Michel, D. Benninger, V. Dietz and H. J. A. van Hedel
464-469
ORIGINAL COMMUNICATION
Predicting recovery after intracerebral hemorrhage – An external validation in patients from controlled clinical trials
C. Weimar, A. Ziegler, R. L. Sacco, H. C. Diener and I. R. König, et al.
470-482
ORIGINAL COMMUNICATION
Influence of task complexity during coordinated hand and foot movements in MS patients with and without fatigue
A kinematic and functional MRI study
M. A. Rocca, R. Gatti, F. Agosta, P. Broglia and P. Rossi, et al.
483-487
ORIGINAL COMMUNICATION
The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation
Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel
Sharon Hassin-Baer, Yael Laitman, Esther Azizi, Irena Molchadski and Gilli Galore-Haskel, et al.
488-492
ORIGINAL COMMUNICATION
Chocolate consumption is increased in Parkinson’s disease
Results from a self-questionnaire study
M. Wolz, A. Kaminsky, M. Löhle, R. Koch and A. Storch, et al.
493-498
ORIGINAL COMMUNICATION
Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s Disease
C. H. Williams-Gray, A. Goris, M. Saiki, T. Foltynie and D. A. S. Compston, et al.
499-501
LETTER TO THE EDITORS
Acute cervical radiculopathies in spontaneous intracranial hypotension
K. A. Kleopa and K. Natsiopoulos
502-503
PIONEERS IN NEUROLOGY
Alois Alzheimer (1864–1915)
F. R. J. Verhey
504-505
PIONEERS IN NEUROLOGY
Arnold Pick (1851–1924)
D. Todman
506-508
JOURNAL CLUB
The efficacy of novel treatments for well-known diseases
Michael Strupp
509-512
COMMUNICATIONS
Communications of the European Neurological Society
Clay E. Reilly